抗瓜氨酸化蛋白的IgA同种型抗体与高危个体进展为类风湿关节炎相关
该研究在健康对照、类风湿关节炎(RA)高危个体和RA患者中横断面检测血清IgA1与IgA2型抗瓜氨酸化蛋白抗体(ACPA)水平,并随访高危个体14个月观察RA进展。结果显示约三分之二高危个体IgA1和IgA2 ACPA阳性,仅IgA1 ACPA阳性与14个月内进展为RA相关,且IgA1 ACPA水平在RA发病时及发病后早期下降,该下降在第二个独立队列中得到验证。
要点
- 约三分之二RA高危个体血清IgA1和IgA2 ACPA阳性,水平与IgG ACPA阳性RA患者相当。
- 仅IgA1 ACPA阳性与高危个体14个月内进展为RA相关,IgA2 ACPA阳性无此关联。
- IgA1 ACPA水平在RA发病时及发病后早期下降,并在第二个独立队列中得到验证。
核心结论
- IgA1和IgA2 ACPA均存在于RA高危个体中,但仅IgA1 ACPA与进展为RA相关。
- RA发病前观察到的血清IgA1 ACPA水平下降可能提示疾病发作前屏障通透性开始增加。
研究设计与样本
- 在健康对照、RA高危个体和RA患者中横断面检测血清IgA1和IgA2 ACPA水平。
- 比较RA高危个体在14个月随访期间进展为RA的频率。
- 对RA发病前、发病时及发病后的血清IgA1和IgA2 ACPA水平进行纵向检测。
- 在第二个独立队列中验证IgA1 ACPA水平的下降。
主要发现
- 约三分之二RA高危个体血清IgA1和IgA2 ACPA阳性,水平与IgG ACPA阳性RA患者相当。
- IgA1 ACPA阳性与RA高危状态在随后14个月内 transition 为RA相关,IgA2 ACPA阳性无此关联。
- 在 transition 过程中,IgA1 ACPA水平在RA发病时下降,并在RA早期继续下降。
- 该下降在第二个独立队列中得到确认。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Events triggering disease outbreak in individuals at-risk for rheumatoid arthritis (RA at-risk) remain unclear, and the role of the various anticitrullinated protein antibody (ACPA) isotypes in this process is still to be established. We aimed to investigate the prevalence of IgA ACPA in RA at-risk individuals, their role in the transition from the RA at-risk status to RA and their dynamics during this transition. METHODS: Cross-sectional measurement of serum IgA1 and IgA2 ACPA levels was conducted in healthy controls, RA at-risk individuals and patients with RA and compared with the frequency of RA development in at risk individuals during a follow-up of 14 months. In addition, longitudinal measurements of serum IgA1 and IgA2 ACPA levels prior to, at and after the onset of RA were performed. RESULTS: Approximately two-thirds of RA at-risk individuals were positive for serum IgA1 and IgA2 ACPA in levels comparable to IgG ACPA positive patients with RA. IgA1, but not IgA2 ACPA positivity was associated with the transition from the RA at-risk state to RA within the following 14 months. Interestingly, during this transition process, IgA1 ACPA levels declined at RA onset and also thereafter during the early phase of RA. This decline was confirmed in a second, independent cohort. CONCLUSION: Both IgA1 and IgA2 ACPA are present in RA at-risk individuals, but only IgA1 ACPA are associated with the progression to RA. The observed decline in serum IgA1 ACPA levels before the onset of RA might indicate starting barrier leakiness prior to disease outbreak.
引用
- Sokolova MV, Hartmann F, Sieghart D, et al. Antibodies against citrullinated proteins of IgA isotype are associated with progression to rheumatoid arthritis in individuals at-risk. RMD Open. 2023. PMID: 36717186. doi:10.1136/rmdopen-2022-002705
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。